Abiopharma

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Air Products and Chemicals, Inc. - APD

HALEON PLC (HLN) Files Form 6-K

New Form 25-NSE - QIAGEN N.V. Filed: 2026-01-08 AccNo: 0000876661-26-000016 Size: 4 KB

📋 Hui Yvonne (Officer) plans to sell 372 shares of Phreesia, Inc. (at $17.47 each, total $6K) Filed: Jan 08, 2026 | ID: 000202

New Form SCHEDULE 13G/A - 10x Genomics, Inc. Filed: 2026-01-08 AccNo: 0000315066-26-000056 Size: 14 KB

New Form SCHEDULE 13G/A - VERACYTE, INC. Filed: 2026-01-08 AccNo: 0001104659-26-001972 Size: 13 KB

New Form SC TO-I/A - Anebulo Pharmaceuticals, Inc. Filed: 2026-01-08 AccNo: 0001493152-26-000914 Size: 55 KB

📋 Sofinnova Crossover I SLP (Affiliate) plans to sell 1.0M shares of Abivax S.A. (at $133.70 each, total $133.7M) Filed: Jan 08, 2026 | ID: 001973

CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT

VolitionRx Secures $2.0 Million in Funding

Akari Therapeutics to Present at the 2026 Biotech Showcase

Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock

(10% Negative) TANGO THERAPEUTICS, INC. (TNGX) Announces Clinical Trial Timeline Adjustment

(10% Negative) Atea Pharmaceuticals, Inc. (AVIR) Announces Delay in priorities Trials for serious viral diseases Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer